ADVM vs. LEGN

In the year-to-date period, ADVM achieves a -33.19% return, which is significantly lower than LEGN's -1.54% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Adverum Biotechnologies, Inc. (ADVM) and Legend Biotech Corporation (LEGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ADVM Sharpe Ratio is -0.97, which is lower than the LEGN Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of ADVM and LEGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ADVM nor LEGN has paid dividends to shareholders.

The maximum ADVM drawdown since its inception was -99.55%, which is greater than LEGN's maximum drawdown of -60.46%. Use the drawdown chart below to compare losses from any high point for ADVM and LEGN. For additional features, visit the drawdowns tool.

Adverum Biotechnologies, Inc. (ADVM) has a higher volatility of 26.89% compared to Legend Biotech Corporation (LEGN) at 13.25%. This indicates that ADVM's price experiences larger fluctuations and is considered to be riskier than LEGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Adverum Biotechnologies, Inc. and Legend Biotech Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.